We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Review · March 23, 2021

Cytoreductive Nephrectomy in the Era of Targeted and Immunotherapy for Metastatic Renal Cell Carcinoma

Critical Reviews in Oncology / Hematology


Additional Info

Critical Reviews in Oncology / Hematology
Cytoreductive Nephrectomy in the Era of Targeted- and Immuno-Therapy for Metastatic Renal Cell Carcinoma: An Elusive Issue? A Systematic Review of the Literature
Crit. Rev. Oncol. Hematol 2021 Apr 01;160(xx)103293, G Mazzaschi, F Quaini, M Bersanelli, S Buti

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading